Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Adopts A Positive Opinion To Update Therapeutic Indication For Soliris- A. M. Castle (NYSE:CAS), Concho Resources (NYSE:CXO)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) reported that the European Medicines Agency has adopted a Positive Opinion to update the therapeutic indication for Soliris in the treatment of paroxysmal nocturnal haemoglobinuria (PNH) ...
